Information to help you learn about SCEMBLIX
Here are support materials that give you more information about SCEMBLIX and Ph+ CML in chronic phase and tools that help you work with your doctor.
SCEMBLIX Patient Guide
Doctor Discussion Guide
Financial Assistance Brochure
Reach out to others with Ph+ CML in chronic phase
Ph+ CML in chronic phase is considered a rare cancer—and it can be difficult to find other patients like yourself. The following organizations may be a helpful source of connections, information, and support.
The Leukemia & Lymphoma Society®
www.LLS.org ↗
1-800-955-4572
The Max Foundation
www.themaxfoundation.org/contact/ ↗
1-425-778-8660
CancerCare®
www.cancercare.org ↗
1-800-813-HOPE (1-800-813-4673)
Leukemia Research Foundation
https://leukemiarf.org/ ↗
1-847-424-0600
American Cancer Society®
www.cancer.org ↗
1-800-ACS-2345 (1-800-227-2345)
National Patient Advocate Foundation
www.npaf.org ↗
1-202-347-8009
The organizations and websites listed on this page are maintained by third parties over whom Novartis Pharmaceuticals Corporation has no control. As such, Novartis Pharmaceuticals Corporation makes no representation as to the accuracy or any other aspect of the information supplied by these organizations or contained in these websites.
Ph+ CML-CP, Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
*Limitations apply. Valid only for those with private insurance. The Program includes the Co-Pay Plus offer, Plus Card (if applicable), and Rebate, with a combined annual limit. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state healthcare program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or healthcare savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the United States and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.